a50065735.htm
 
 
UNITED STATES
  
 
SECURITIES AND EXCHANGE COMMISSION
SEC FILE NUMBER
 
Washington, D.C. 20549
  
   
001-33796
 
FORM 12b-25
  
   
CUSIP NUMBER
 
NOTIFICATION OF LATE FILING
  
    16934Q
 
(Check one):  o Form 10-K  o Form 20-F  o Form 11-K  x  Form 10-Q  o Form 10-D  o Form N-SAR Form  o N-CSR
 
For Period Ended:                                September 30, 2011
 
o Transition Report on Form 10-K
 
o Transition Report on Form 20-F
 
o Transition Report on Form 11-K
 
o Transition Report on Form 10-Q
 
o Transition Report on Form N-SAR
 
For the Transition Period Ended: ______________________
 
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has verified any information contained herein.
 
 
 
If the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
 
 
PART I — REGISTRANT INFORMATION
 
Chimera Investment Corporation
Full Name of Registrant
 
 
Former Name if Applicable
 
1211 Avenue of the Americas, Suite 2902
Address of Principal Executive Office (Street and Number)
 
New York, New York 10036
City, State and Zip Code
 
 
 
 
 
 
 
PART II — RULES 12b-25(b) AND (c)
 
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check box if appropriate)
 
x
(a) The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
 
(b) The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day following the prescribed due date; and
 
(c) The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.

 
PART III — NARRATIVE
 
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q,10-D, N-SAR, N-CSR, or the transition report or portion thereof, could not be filed within the prescribed time period.
 
Chimera Investment Corporation (the “Company”), in conjunction with the review by its outside independent accounting firm, is completing an analysis of the application under generally accepted accounting principles (GAAP) of the appropriate Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) to other-than-temporary impairments (OTTI).  Prior to September 30, 2011, the Company evaluated certain of its investments in securities for OTTI under ASC 320 Investments-Debt and Equity Securities.  The Company has determined that its investments in securities rated less than AA, as well as non-rated non-Agency securities and other subordinate securities, should be evaluated for impairment under ASC 325- Investments-Other – Beneficial Interest in Securitized Transactions.
 
 
 
 
 
PART IV — OTHER INFORMATION
 
(1)
Name and telephone number of person to contact in regard to this notification
  
             
A. Alexandra Denahan
 
(212)
  
696-0100
  
(Name)
  
(Area Code)
  
(Telephone Number)
  
       
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed ? If answer is no, identify report(s).
 
x Yes                      o No
        
             
             
(3)
 
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof ?  x Yes o No
             
  If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
             
  As described in Part III above, the Company has not completed an analysis of the treatment under GAAP of OTTI related to the Company’s investments in securities rated less than AA, non-rated non-Agency securities and other subordinate securities.  Therefore, the Company is currently unable to provide a reasonable estimate of any significant change in the Company’s results of operations for the quarter and nine months ended September 30, 2011 as compared to the corresponding periods in 2010. 
 
Cautionary Statement Regarding Forward-Looking Information
 
This filing contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, relating to the Company’s expected financial results and financial statements. The Company intends forward-looking terminology such as “believes,” “expects,” “may,” “will,” “should,” “anticipates,” “plans,” or similar expressions to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause the Company’s actual results to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to, the risk that additional information may arise during the course of the Company’s review of asset impairment charges that would require the Company to make additional adjustments, and further delay the filing of the Company’s third quarter Form 10-Q, as well as other risks described more fully in Item 1A in the Company’s Annual Report on Form 10-K, which is expressly incorporated herein by reference, and other factors as may periodically be described in the Company’s filings with the SEC.
 
 
 
 
 
Chimera Investment Corporation
(Name of Registrant as Specified in Charter)
 
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date
November 10, 2011
  
By
/s/ A. Alexandra Denahan
  
       
A. Alexandra Denahan